AEMD
Aethlon Medical Inc
NASDAQ · Health Care
$2.23
+0.09 (+4.21%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.23M | 1.11M | 1.30M |
| Net Income | 77.3K | 83.3K | 93.6K |
| EPS | — | — | — |
| Profit Margin | 6.3% | 7.5% | 7.2% |
| Rev Growth | -2.9% | +4.8% | +4.6% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 322.6K | 327.3K | 309.8K |
| Total Equity | 1.17M | 1.21M | 1.20M |
| D/E Ratio | 0.28 | 0.27 | 0.26 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 133.0K | 129.5K | 140.0K |
| Free Cash Flow | 122.8K | 83.4K | 112.3K |